Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy
WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, and 3E Bioventures...

Arsenal made winning at Anfield look routine
In Telangana, the Ravana jibe masks a quiet fiscal win
18-year-old Rew leads England Lions against West Indies A in St Kitts
SRK’s King drops its first song on his birthday. A ₹100-crore opener is the goal
Sindhu and Lakshya Sen Deliver Double Glory at Hylo Open 
















